Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

朝まで勝手に勉強会(眼科の最新論文を紹介)

141回 Bispecific抗体Faricimabについて

29 Jun 2022

Description

Retina2021年1月のTHE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review、LANCET2022年2月のEfficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials、LANCET2022年2月のEfficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trialsを読みました

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.